Literature DB >> 30957071

The Persistent Neurotoxic Effects of Methamphetamine on Dopaminergic and Serotonergic Markers in Male and Female Rats.

Lisa M McFadden1,2, Paula L Vieira-Brock1.   

Abstract

OBJECTIVE: Methamphetamine (METH) is a highly addictive substance abused world-wide in both males and females. Preclinical studies in male rodents suggest that large-dose exposure to METH can lead to persistent neurotoxic consequences to various brain regions. However, little research has focused on the potential role of sex in the neurotoxic consequences of METH exposure.
METHODS: The current study exposed male and female rats to large-doses of METH (4 injections of 7.5 mg/kg) or saline. Hyperthermia was promoted in the females exposed to METH such that similar hyperthermia occurred in males and females. Rats were sacrificed 8 d later and neurochemical changes were assessed in the striatum, hippocampus, frontal cortex and olfactory bulbs.
RESULTS: Results revealed that male and female rats exposed to METH had similar decreases in dopamine (DA) transporter (DAT) immunoreactivity in the striatum, serotonin (5-HT) content and 5-HT transporter (SERT) function in the hippocampus, and 5-HT content in the frontal cortex. However, female rats exposed to METH had greater decreases in 5-HT content in the olfactory bulbs compared to sex-matched controls while male rats exposed to METH did not significantly differ from sex-matched controls.
CONCLUSIONS: These findings suggest that when similar hyperthermia is maintained between male and female rats exposed to METH, the neurotoxic effects of METH were similar in some, but not all brain regions.

Entities:  

Keywords:  Frontal cortex; Hippocampus; Methamphetamine; Olfactory bulbs; Sex-differences; Striatum

Year:  2016        PMID: 30957071      PMCID: PMC6448800          DOI: 10.4172/2476-2067.1000116

Source DB:  PubMed          Journal:  Toxicol Open Access        ISSN: 2476-2067


  36 in total

1.  Methamphetamine use among treatment-seeking adolescents in Southern California: participant characteristics and treatment response.

Authors:  Richard A Rawson; Rachel Gonzales; Jeanne L Obert; Michael J McCann; Paul Brethen
Journal:  J Subst Abuse Treat       Date:  2005-09

Review 2.  Implications of chronic methamphetamine use: a literature review.

Authors:  Charles W Meredith; Craig Jaffe; Kathleen Ang-Lee; Andrew J Saxon
Journal:  Harv Rev Psychiatry       Date:  2005 May-Jun       Impact factor: 3.732

3.  Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats.

Authors:  Alessandra Milesi-Hallé; Howard P Hendrickson; Elizabeth M Laurenzana; W Brooks Gentry; S Michael Owens
Journal:  Toxicol Appl Pharmacol       Date:  2005-12-15       Impact factor: 4.219

4.  Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo.

Authors:  K E Sabol; J T Roach; S L Broom; C Ferreira; M M Preau
Journal:  Brain Res       Date:  2001-02-16       Impact factor: 3.252

5.  Methamphetamine administration causes death of dopaminergic neurons in the mouse olfactory bulb.

Authors:  Xiaolin Deng; Bruce Ladenheim; Subramaniam Jayanthi; Jean Lud Cadet
Journal:  Biol Psychiatry       Date:  2006-12-08       Impact factor: 13.382

6.  Predicting in-treatment performance and post-treatment outcomes in methamphetamine users.

Authors:  Maureen P Hillhouse; Patricia Marinelli-Casey; Rachel Gonzales; Alfonso Ang; Richard A Rawson
Journal:  Addiction       Date:  2007-04       Impact factor: 6.526

7.  The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.

Authors:  J F Bowyer; A W Tank; G D Newport; W Slikker; S F Ali; R R Holson
Journal:  J Pharmacol Exp Ther       Date:  1992-02       Impact factor: 4.030

8.  Identifying methamphetamine users at risk for major depressive disorder: findings from the methamphetamine treatment project at three-year follow-up.

Authors:  Suzette Glasner-Edwards; Larissa J Mooney; Patricia Marinelli-Casey; Maureen Hillhouse; Alfonso Ang; Richard Rawson
Journal:  Am J Addict       Date:  2008 Mar-Apr

9.  Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges.

Authors:  Devon L Graham; Pierre-A H Noailles; Jean Lud Cadet
Journal:  J Neurochem       Date:  2008-02-01       Impact factor: 5.372

10.  Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure.

Authors:  John F Bowyer; Bonnie Robinson; Syed Ali; Larry C Schmued
Journal:  Synapse       Date:  2008-03       Impact factor: 2.562

View more
  3 in total

1.  Meta-Analysis of Methamphetamine Modulation on Amyloid Precursor Protein through HMGB1 in Alzheimer's Disease.

Authors:  Sedra Alabed; Heping Zhou; Ilker K Sariyer; Sulie L Chang
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 2.  Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts.

Authors:  Atul P Daiwile; Subramaniam Jayanthi; Jean Lud Cadet
Journal:  Neurosci Biobehav Rev       Date:  2022-04-20       Impact factor: 9.052

Review 3.  Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies.

Authors:  Giulia Costa; Maria Antonietta De Luca; Gessica Piras; Jacopo Marongiu; Liana Fattore; Nicola Simola
Journal:  Neural Regen Res       Date:  2020-05       Impact factor: 5.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.